GuangYuYuan Chinese Herbal Medicine Co., Ltd.

XSSC:600771 Stock Report

Market Cap: CN¥9.5b

GuangYuYuan Chinese Herbal Medicine Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Hui Miao

Chief executive officer

CN¥948.0k

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownershipn/a
Management average tenure4.3yrs
Board average tenure1.9yrs

Recent management updates

Recent updates

CEO

Hui Miao (49 yo)

2.3yrs

Tenure

CN¥948,000

Compensation

Mr. Hui Miao was the Director of Shanxi Zhendong Pharmaceutical Co.,Ltd from May 22, 2020 until June 17, 2022. He serves as Director at GuangYuYuan Chinese Herbal Medicine Co., Ltd. since October 17, 2022...

Leadership Team

NamePositionTenureCompensationOwnership
Hui Miao
President & Director2.3yrsCN¥948.00kno data
Yun Tang
Secretary of the Board of Directors4.3yrsCN¥480.00kno data
Orchid Willow
Vice President4.9yrsno datano data

4.3yrs

Average Tenure

50yo

Average Age

Experienced Management: 600771's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Hui Miao
President & Director2.2yrsCN¥948.00kno data
Zhaowei Liu
Director3yrsno datano data
Xiao Jun Li
Chairmanless than a yearno datano data
Bo Yang
Vice Chairman1.9yrsno datano data
Xueyan Zhen
Independent Director1.9yrsCN¥96.00kno data
Huazhong Zhang
Chairman of the Supervisory Board1.9yrsno datano data
Zhengren Hu
Supervisor1.9yrsno datano data
Feng Wang
Employee Representative Supervisor1.9yrsno datano data

1.9yrs

Average Tenure

49.5yo

Average Age

Experienced Board: 600771's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 18:42
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GuangYuYuan Chinese Herbal Medicine Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bin WuChina Merchants Securities Co. Ltd.
Min QiuChina Merchants Securities Co. Ltd.
Zhouyu DengGuosen Securities Co., Ltd.